Literature DB >> 20706066

Are there predictors of outcome following rectovaginal fistula repair?

Rodrigo A Pinto1, Thais V Peterson, Sherief Shawki, G Willy Davila, Steven D Wexner.   

Abstract

BACKGROUND: Rectovaginal fistula is a distressing condition for patients and for physicians who are continuously challenged in providing durable treatment options. The aim of this study is to assess the results of rectovaginal fistula repair and identify predictive factors for poor outcome.
METHODS: Retrospective analysis of patients who underwent rectovaginal fistula repair from 1988 to 2008 was performed. chi tests and logistical regression analysis were used to study treatment outcomes according to the following fistula characteristics: etiology, size, location, and number of prior attempts at fistula repair. In addition, patient factors such as age, body mass index, smoking history, comorbid condition of diabetes, use of steroid and immunosuppressive medications, number of prior vaginal deliveries, and presence of a diverting stoma were analyzed.
RESULTS: A total of 184 procedures were performed in 125 patients. Inflammatory bowel disease was the most common indication for surgery (45.6%), followed by obstetric injury (24%) and surgical trauma (16%). The mean duration of fistula presence was 31.2 months. The procedures performed included endorectal advancement flap (35.3%), gracilis muscle interposition (13.6%), seton placement (13.6%), and transperineal (8.7%) and transvaginal repair (8.1%). The overall success rate per procedure was 60%, with no difference in recurrence rates based on the type of repair. Patients with Crohn's disease had more recurrent fistulas (44.2% success per procedure; P < .01), although 78% eventually healed after an average of 1.8 procedures. Patients with obstetric injuries had an 89% success rate after an average of 1.3 procedures per patient, which is similar to the success rate for traumatic fistulas. Pouch vaginal fistulas had a 91% success rate after an average of 1.6 procedures per patient. The overall success rate per patient was 88% after multiple procedures with a mean follow-up of 16.3 months. Age, body mass index, diabetes, use of steroids and immunosuppressive agents, size and location of the fistula, number of vaginal deliveries, time interval between a recurrent episode and subsequent repair, and the presence of fecal diversion did not affect outcomes. The presence of Crohn's disease and a smoking history are strongly associated with rectovaginal fistula recurrence (P = .02).
CONCLUSIONS: Despite a relatively low initial success rate (60%), most rectovaginal fistulas can be successfully repaired with subsequent operations. Crohn's disease and smoking are associated with adverse outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20706066     DOI: 10.1007/DCR.0b013e3181e536cb

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  33 in total

1.  Surgical Approach for Repair of Rectovaginal Fistula by Modified Martius Flap.

Authors:  M Reichert; T Schwandner; A Hecker; A Behnk; E Baumgart-Vogt; F Wagenlehner; W Padberg
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

2.  Clinical outcome and quality of life after gracilis muscle transposition for fistula closure over a 10-year period.

Authors:  M Grott; A Rickert; S Hetjens; P Kienle
Journal:  Int J Colorectal Dis       Date:  2021-01-02       Impact factor: 2.571

Review 3.  Management of anoperineal lesions in Crohn's disease: a French National Society of Coloproctology national consensus.

Authors:  D Bouchard; F Pigot; G Staumont; L Siproudhis; L Abramowitz; P Benfredj; C Brochard; N Fathallah; J-L Faucheron; T Higuero; Y Panis; V de Parades; B Vinson-Bonnet; D Laharie
Journal:  Tech Coloproctol       Date:  2019-01-02       Impact factor: 3.781

4.  Post surgical rectovaginal fistula: who really benefits from stoma diversion?

Authors:  Giuliano Barugola; Elisa Bertocchi; Alessandra Leonardi; Alex M Almoudaris; Giacomo Ruffo
Journal:  Updates Surg       Date:  2020-05-24

5.  Efficacy of autologous fat graft injection in the treatment of anovaginal fistulas.

Authors:  S Norderval; L Lundby; H Hougaard; S Buntzen; S Weum; L de Weerd
Journal:  Tech Coloproctol       Date:  2017-12-28       Impact factor: 3.781

6.  Gracilis muscle transposition for the treatment of recurrent rectovaginal and pouch-vaginal fistula: is Crohn's disease a risk factor for failure? A prospective cohort study.

Authors:  Matteo Rottoli; Carlo Vallicelli; Luca Boschi; Riccardo Cipriani; Gilberto Poggioli
Journal:  Updates Surg       Date:  2018-07-07

7.  Repair of a recurrent traumatic rectovaginal fistula using vaginal wall plication to reinforce a rectal wall advancement flap.

Authors:  Jeremy Sugrue; Jan Kaminski; Supriya Patel; John Park; Leela Prasad; Slawomir Marecik
Journal:  J Vis Surg       Date:  2016-03-24

8.  Rectovaginal fistula repair using a gracilis muscle flap.

Authors:  Erik D Hokenstad; Ziyad S Hammoudeh; Nho V Tran; Heidi K Chua; John A Occhino
Journal:  Int Urogynecol J       Date:  2016-01-25       Impact factor: 2.894

9.  Uncommon acquired fistulae involving the digestive system: summary of data.

Authors:  I Ashkenazi; O Olsha; B Kessel; M M Krausz; R Alfici
Journal:  Eur J Trauma Emerg Surg       Date:  2011-05-12       Impact factor: 3.693

10.  Novel treatment for recalcitrant rectovaginal fistulas: fat injection.

Authors:  L de Weerd; S Weum; S Norderval
Journal:  Int Urogynecol J       Date:  2014-09-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.